The article analyzes three Berkshire Hathaway holdings: DaVita and Kraft Heinz are recommended as strong buys due to positive earnings surprises and undervaluation, while UnitedHealth Group should be avoided despite recent dips, as it trades at a premium valuation with a deteriorating growth story amid lower Medicare Advantage payment increases.

Greg Abel, the new CEO of Berkshire Hathaway, has made his first reported stock sale by divesting 1.7 million shares of DaVita under a contractual agreement. The article also highlights Kraft Heinz as a potential candidate for sale, as Abel has registered to sell nearly all of Berkshire's 325 million shares and expressed disapproval of the company's planned split into two entities.

DaVita Inc. (NYSE: DVA) surged 21.69% after reporting Q4 adjusted earnings of $3.40 per share, beating consensus of $3.16, and sales of $3.62 billion, up 5.8% YoY. The kidney care provider issued optimistic 2026 guidance with adjusted earnings of $13.60-$15.00 per share versus consensus of $12.65. The company also announced a $200 million minority investment in Elara Caring alongside Ares' Private Equity Group.

DaVita stock surged 20.3% on Tuesday following better-than-expected Q4 2024 earnings and improved full-year 2025 guidance. The dialysis treatment company reported adjusted EPS of $3.40 versus $2.51 year-over-year and projects 2025 EPS between $13.60-$15.00, significantly above the $10.78 achieved in 2024. Despite ongoing challenges from insurance reimbursement pressures and competition from home-based dialysis options, the stock appears undervalued at approximately 10x forward earnings.

A new American Heart Association initiative highlights the interconnected health of heart, kidney, and metabolic systems, revealing that 9 in 10 U.S. adults have at least one component of CKM syndrome, which increases risks of heart attack, stroke, and heart failure.

Warren Buffett's Berkshire Hathaway recommends three stocks currently out of favor: DaVita, Kraft Heinz, and Pool Corporation. Each stock offers unique investment potential despite current market challenges.

The article highlights three healthcare stocks trading at attractive valuations: DaVita, Merck, and Universal Health Services, which offer potential investment opportunities despite current market challenges.

The article analyzes Warren Buffett's investment portfolio, highlighting promising stocks like DaVita and BYD Company, while cautioning against homebuilding stocks like Lennar due to current market conditions.

Rockwell Medical reported Q2 2025 earnings with a 37.8% revenue decline due to losing its largest customer, but signed four new multi-year supply agreements and maintained tight cost controls.

The Q1 2025 earnings season has seen mostly positive results from S&P 500 companies, with 78% beating Wall Street's expectations. However, some consumer-facing companies like Wynn, Clorox, and Restaurant Brands International reported weaker-than-anticipated profits and revenues, suggesting potential cracks in consumer spending.

The article predicts that Warren Buffett will reveal an increase in one of Berkshire Hathaway's biggest investment holdings during the company's upcoming annual shareholder meeting on May 3. It also discusses Buffett's recent stock purchases and the potential for individual investors to find value in smaller companies.

DaVita, a healthcare company, suffered a ransomware attack that disrupted its operations. Investors reacted negatively, causing a 10% drop in the stock price, due to the uncertainty around the full impact of the attack.